VX-702 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

VX 702 is a p38 MAP kinase pathway inhibitor.

Biologische Aktivit?t

Orally active, ATP-competitive inhibitor of p38α MAPK; also inhibits p38β (K D values are 3.7 and 17 nM respectively).

VX-702 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

VX-702 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Capot Chemical Co.,Ltd.	+86-（0）57185586718 +86-13336195806	sales@capot.com	China	29793	60
Biochempartner	0086-13720134139	candy@biochempartner.com	CHINA	965	58
Zhejiang J&C Biological Technology Co.,Limited	+1-2135480471 +1-2135480471	sales@sarms4muscle.com	China	10473	58
Amadis Chemical Company Limited	571-89925085	sales@amadischem.com	China	131957	58
Shanghai Boyle Chemical Co., Ltd.		sales@boylechem.com	China	2922	55
3B Pharmachem (Wuhan) International Co.,Ltd.	821-50328103-801 18930552037	3bsc@sina.com	China	15839	69
JinYan Chemicals(ShangHai) Co.,Ltd.	13817811078	sales@jingyan-chemical.com	China	9976	60
Xi’an chemsoar Medical Technology Co., ltd	029-86538357		China	234	57
Shanghai civi chemical technology co.,Ltd	86-21-34053660	sale@labgogo.com	China	9865	52
Beijing HuaMeiHuLiBiological Chemical	010-56205725	waley188@sohu.com	China	12335	58

---

• 1-(5-CarbaMoyl-6-(2,4-difluorophenyl)pyridin-2-yl)-1-(2,6-difluorophenyl)urea
• CS-363
• 6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)pyridine-3-carboxamide
• 479543-46-9
• C19H12F4N4O2
• MAPK